Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02236013
1:21:treatment,,
Preemptive treatment with retinoic acid prior to exclusion of APL ≤ 7 days
3
[ "Preemptive", "treatment", "with", "retinoic", "acid", "prior", "to", "exclusion", "of", "APL", "≤", "7", "days" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02349958
9:19:cancer,50:63:chronic_disease,58:63:cancer,
Uterine malignancy of the corpus, or cervix with primary tumor Stage IIIA or greater, or recurrent tumor confined to the abdomen
3
[ "Uterine", "malignancy", "of", "the", "corpus", ",", "or", "cervix", "with", "primary", "tumor", "Stage", "IIIA", "or", "greater", ",", "or", "recurrent", "tumor", "confined", "to", "the", "abdomen" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03028012
1:27:chronic_disease
Pre-existing renal disease
3
[ "Pre-existing", "renal", "disease" ]
[ 2, 2, 2 ]
NCT02497690
8:24:chronic_disease
severe motor impairment
3
[ "severe", "motor", "impairment" ]
[ 0, 2, 2 ]
NCT02514070
12:27:cancer
History of prostate Cancer
3
[ "History", "of", "prostate", "Cancer" ]
[ 0, 0, 3, 3 ]
NCT02932280
,,24:35:treatment,
Hemoglobin < 8.0 g/dL (transfusion permitted at least 7 days prior to baseline)
3
[ "Hemoglobin", "<", "8.0", "g/dL", "(", "transfusion", "permitted", "at", "least", "7", "days", "prior", "to", "baseline", ")" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01799135
37:78:treatment
Adequate renal function to tolerate intravenous gadolinium contrast injection
3
[ "Adequate", "renal", "function", "to", "tolerate", "intravenous", "gadolinium", "contrast", "injection" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT01312857
37:62:cancer,63:86:cancer,132:152:chronic_disease
History of histologically confirmed colorectal adenocarcinoma metastatic to the liver with no clinical or radiographic evidence of extrahepatic disease
3
[ "History", "of", "histologically", "confirmed", "colorectal", "adenocarcinoma", "metastatic", "to", "the", "liver", "with", "no", "clinical", "or", "radiographic", "evidence", "of", "extrahepatic", "disease" ]
[ 0, 0, 0, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02374918
35:39:chronic_disease
The occurrence of a concussion or mTBI must be documented by a medical report or other professional witness documentation
3
[ "The", "occurrence", "of", "a", "concussion", "or", "mTBI", "must", "be", "documented", "by", "a", "medical", "report", "or", "other", "professional", "witness", "documentation" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02464878
1:15:chronic_disease,
AAT deficiency (defined as < 1.0ng/mg AAT)
3
[ "AAT", "deficiency", "(", "defined", "as", "<", "1.0ng/mg", "AAT", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02697201
1:10:chronic_disease
Sedentary
3
[ "Sedentary" ]
[ 2 ]
NCT02754752
1:36:cancer
Metastatic breast cancer (stage IV)
3
[ "Metastatic", "breast", "cancer", "(", "stage", "IV", ")" ]
[ 3, 3, 3, 3, 3, 0, 0 ]
NCT02950337
22:61:chronic_disease
Patients with severe obstructive or restrictive lung disease
3
[ "Patients", "with", "severe", "obstructive", "or", "restrictive", "lung", "disease" ]
[ 0, 0, 0, 2, 2, 2, 2, 2 ]
NCT03093272
1:16:cancer
Prostate cancer progression on or since last treatment as documented by PSA rise or bone progression according to PCWG2 or soft tissue radiographic progression according to RECIST criteria Version 1.1
3
[ "Prostate", "cancer", "progression", "on", "or", "since", "last", "treatment", "as", "documented", "by", "PSA", "rise", "or", "bone", "progression", "according", "to", "PCWG2", "or", "soft", "tissue", "radiographic", "progression", "according", "to", "RECIST", "criteria", "Version", "1.1" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02033616
28:44:cancer,73:98:treatment,136:147:treatment,151:161:treatment,238:247:treatment
Patients with one or a few brain metastases that have been treated with stereotactic radiotherapy consisting of a single dose, such as Gamma Knife or Cyberknife, are allowed to be included in the study, but need wait one week after such treatment
3
[ "Patients", "with", "one", "or", "a", "few", "brain", "metastases", "that", "have", "been", "treated", "with", "stereotactic", "radiotherapy", "consisting", "of", "a", "single", "dose", ",", "such", "as", "Gamma", "Knife", "or", "Cyberknife", ",", "are", "allowed", "to", "be", "included", "in", "the", "study", ",", "but", "need", "wait", "one", "week", "after", "such", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02628535
18:44:chronic_disease,18:29:chronic_disease,72:115:chronic_disease,120:131:chronic_disease
Known history of hepatitis B or C infection or known positive test for hepatitis B surface antigen or core antigen, or hepatitis C polymerase chain reaction (PCR)
3
[ "Known", "history", "of", "hepatitis", "B", "or", "C", "infection", "or", "known", "positive", "test", "for", "hepatitis", "B", "surface", "antigen", "or", "core", "antigen", ",", "or", "hepatitis", "C", "polymerase", "chain", "reaction", "(", "PCR", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02520427
12:31:chronic_disease,37:43:chronic_disease,47:72:chronic_disease,,95:104:chronic_disease,115:138:treatment,
History of arterial thrombosis (eg, stroke or transient ischemic attack) in the past 3 months Infection requiring intravenous antibiotics within 1 week of study enrollment (day 1)
3
[ "History", "of", "arterial", "thrombosis", "(", "eg", ",", "stroke", "or", "transient", "ischemic", "attack", ")", "in", "the", "past", "3", "months", "Infection", "requiring", "intravenous", "antibiotics", "within", "1", "week", "of", "study", "enrollment", "(", "day", "1", ")" ]
[ 0, 0, 2, 2, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02367196
24:36:cancer
relapsed or refractory solid tumors
3
[ "relapsed", "or", "refractory", "solid", "tumors" ]
[ 0, 0, 0, 3, 3 ]
NCT02901041
1:17:chronic_disease
Bipolar disorder
3
[ "Bipolar", "disorder" ]
[ 2, 2 ]
NCT02101736
1:25:chronic_disease
unstable angina pectoris
3
[ "unstable", "angina", "pectoris" ]
[ 2, 2, 2 ]
NCT02388685
27:41:chronic_disease
heel cord contracture and foot deformity
3
[ "heel", "cord", "contracture", "and", "foot", "deformity" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT02875301
1:3:chronic_disease
MS
3
[ "MS" ]
[ 2 ]
NCT02311621
23:54:treatment
Must not be receiving external beam radiation therapy at the time of study enrollment
3
[ "Must", "not", "be", "receiving", "external", "beam", "radiation", "therapy", "at", "the", "time", "of", "study", "enrollment" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02235857
1:32:treatment,47:65:chronic_disease,82:94:chronic_disease
Pediatric post renal transplant patients with nephrotic syndrome associated with primary FSGS
3
[ "Pediatric", "post", "renal", "transplant", "patients", "with", "nephrotic", "syndrome", "associated", "with", "primary", "FSGS" ]
[ 1, 1, 1, 1, 0, 0, 2, 2, 0, 0, 2, 2 ]
NCT02350764
6:22:cancer
Have residual disease following surgical resection that is measurable by RECIST v1.1
3
[ "Have", "residual", "disease", "following", "surgical", "resection", "that", "is", "measurable", "by", "RECIST", "v1.1" ]
[ 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02964741
1:18:treatment
Prior use of tDCS
3
[ "Prior", "use", "of", "tDCS" ]
[ 1, 1, 1, 1 ]
NCT01734512
23:32:treatment,34:46:treatment,54:66:treatment
Patients may have had treatment (chemotherapy and/or radiotherapy) for any number of relapses prior to this recurrence
3
[ "Patients", "may", "have", "had", "treatment", "(", "chemotherapy", "and/or", "radiotherapy", ")", "for", "any", "number", "of", "relapses", "prior", "to", "this", "recurrence" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02081404
1:21:chronic_disease
Peptic ulcer disease
3
[ "Peptic", "ulcer", "disease" ]
[ 2, 2, 2 ]
NCT02353728
12:28:chronic_disease
Congenital long QT syndrome or a known family history of long QT syndrome
3
[ "Congenital", "long", "QT", "syndrome", "or", "a", "known", "family", "history", "of", "long", "QT", "syndrome" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02315612
43:55:chronic_disease
A subject will not be excluded because of pancytopenia related to disease
3
[ "A", "subject", "will", "not", "be", "excluded", "because", "of", "pancytopenia", "related", "to", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0 ]
NCT03032328
32:41:chronic_disease,43:53:chronic_disease,58:78:chronic_disease,119:144:chronic_disease
Patients will be excluded if a metabolic, mechanical, or mucosal inflammatory cause has been defined to explain their gastrointestinal symptoms
3
[ "Patients", "will", "be", "excluded", "if", "a", "metabolic", ",", "mechanical", ",", "or", "mucosal", "inflammatory", "cause", "has", "been", "defined", "to", "explain", "their", "gastrointestinal", "symptoms" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02393157
7:47:chronic_disease
Known congenital or acquired immune deficiency
3
[ "Known", "congenital", "or", "acquired", "immune", "deficiency" ]
[ 0, 2, 2, 2, 2, 2 ]
NCT02503722
1:26:chronic_disease
Uncontrolled hypertension
3
[ "Uncontrolled", "hypertension" ]
[ 2, 2 ]
NCT02445339
1:19:chronic_disease,,
Acute liver injury (liver aminotransferase concentrations >5 times the upper limit of normal)
3
[ "Acute", "liver", "injury", "(", "liver", "aminotransferase", "concentrations", ">", "5", "times", "the", "upper", "limit", "of", "normal", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01624090
15:34:cancer
Patients with cerebral metastases
3
[ "Patients", "with", "cerebral", "metastases" ]
[ 0, 0, 3, 3 ]
NCT02382419
11:31:treatment,
Use of an investigational drug in the 3 months prior to screening and must agree to not participate in any drug or device study while enrolled in this study
3
[ "Use", "of", "an", "investigational", "drug", "in", "the", "3", "months", "prior", "to", "screening", "and", "must", "agree", "to", "not", "participate", "in", "any", "drug", "or", "device", "study", "while", "enrolled", "in", "this", "study" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02251431
8:23:treatment
Use of DDP4 inhibitors
3
[ "Use", "of", "DDP4", "inhibitors" ]
[ 0, 0, 1, 1 ]
NCT03108950
1:25:chronic_disease
Severe pulmonary disease
3
[ "Severe", "pulmonary", "disease" ]
[ 2, 2, 2 ]
NCT02278250
,,,,137:147:treatment
Men with pregnant or lactating partners or partners who plan to become pregnant during the study or within 6 months of the last dose of study drug
3
[ "Men", "with", "pregnant", "or", "lactating", "partners", "or", "partners", "who", "plan", "to", "become", "pregnant", "during", "the", "study", "or", "within", "6", "months", "of", "the", "last", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01823198
1:26:cancer
Myelodysplastic syndromes with intermediat
3
[ "Myelodysplastic", "syndromes", "with", "intermediat" ]
[ 3, 3, 0, 0 ]
NCT02512926
,55:80:treatment
At least 14 days must have elapsed since last dose of pegfilgrastim (Neulasta®)
3
[ "At", "least", "14", "days", "must", "have", "elapsed", "since", "last", "dose", "of", "pegfilgrastim", "(", "Neulasta®", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT02267863
5:28:treatment,,,71:90:treatment,112:121:treatment
Off previous cancer therapy for at least 14 days, or 5 half-lives for noncytotoxic agents prior to first study treatment administration
3
[ "Off", "previous", "cancer", "therapy", "for", "at", "least", "14", "days", ",", "or", "5", "half-lives", "for", "noncytotoxic", "agents", "prior", "to", "first", "study", "treatment", "administration" ]
[ 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0 ]
NCT02593123
45:71:cancer
Any of the following high risk or recurrent hematological malignancies
3
[ "Any", "of", "the", "following", "high", "risk", "or", "recurrent", "hematological", "malignancies" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02985554
23:35:treatment,39:51:treatment,96:107:treatment
Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events (AEs) due to agents administered more than 4 weeks earlier
3
[ "Patients", "who", "have", "had", "chemotherapy", "or", "radiotherapy", "within", "4", "weeks", "(", "6", "weeks", "for", "nitrosoureas", "or", "mitomycin", "C", ")", "prior", "to", "entering", "the", "study", "or", "those", "who", "have", "not", "recovered", "from", "adverse", "events", "(", "AEs", ")", "due", "to", "agents", "administered", "more", "than", "4", "weeks", "earlier" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02709980
1:12:chronic_disease
Sleep apnea
3
[ "Sleep", "apnea" ]
[ 2, 2 ]
NCT02554253
21:44:treatment
schedule to undergo complex cardiac surgery
3
[ "schedule", "to", "undergo", "complex", "cardiac", "surgery" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT01505569
1:34:cancer,,
Primary Malignant Brain Neoplasms <18 years of age - at diagnosis and/or relapse
3
[ "Primary", "Malignant", "Brain", "Neoplasms", "<", "18", "years", "of", "age", "-", "at", "diagnosis", "and/or", "relapse" ]
[ 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02778867
17:35:chronic_disease
Have concurrent H pylori gastritis
3
[ "Have", "concurrent", "H", "pylori", "gastritis" ]
[ 0, 0, 2, 2, 2 ]
NCT02366871
13:19:treatment
Concomitant NSAIDS
3
[ "Concomitant", "NSAIDS" ]
[ 0, 1 ]
NCT02468453
17:22:treatment,23:31:treatment,32:46:treatment,67:115:treatment,,155:164:treatment
Having received Botox/collagen/fat injections or other methods of augmentation with injected or implanted material in the treated area within 9 months of treatment or during the study (if face is treated)
3
[ "Having", "received", "Botox/collagen/fat", "injections", "or", "other", "methods", "of", "augmentation", "with", "injected", "or", "implanted", "material", "in", "the", "treated", "area", "within", "9", "months", "of", "treatment", "or", "during", "the", "study", "(", "if", "face", "is", "treated", ")" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01389024
9:34:treatment
Chronic blood transfusion therapy, ongoing or planned
3
[ "Chronic", "blood", "transfusion", "therapy", ",", "ongoing", "or", "planned" ]
[ 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02833207
,31:51:treatment
Regularly (≥5 days/week) take acetylsalicylic acid
3
[ "Regularly", "(", "≥5", "days/week", ")", "take", "acetylsalicylic", "acid" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03158974
182:204:treatment
Are willing and able to participate as an outpatient, making regularly scheduled visits to the study center during the treatment and to comply with all study requirements including concomitant medication and other treatment restrictions
3
[ "Are", "willing", "and", "able", "to", "participate", "as", "an", "outpatient", ",", "making", "regularly", "scheduled", "visits", "to", "the", "study", "center", "during", "the", "treatment", "and", "to", "comply", "with", "all", "study", "requirements", "including", "concomitant", "medication", "and", "other", "treatment", "restrictions" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02706353
26:48:cancer
Patients with history of hematologic malignancy
3
[ "Patients", "with", "history", "of", "hematologic", "malignancy" ]
[ 0, 0, 0, 0, 3, 3 ]
NCT02675114
8:28:chronic_disease,
Severe aortic regurgitation (>3+)
3
[ "Severe", "aortic", "regurgitation", "(", ">", "3+", ")" ]
[ 0, 2, 2, 0, 0, 0, 0 ]
NCT03159702
,,,264:292:treatment,
Females of child bearing potential should agree to practice 2 effective methods of contraception, at the same time, from the time of signing the informed consent form through 90 days after the last dose of study drug and must also adhere to the guidelines of any treatment-specific pregnancy prevention program, if applicable, or agree to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject
3
[ "Females", "of", "child", "bearing", "potential", "should", "agree", "to", "practice", "2", "effective", "methods", "of", "contraception", ",", "at", "the", "same", "time", ",", "from", "the", "time", "of", "signing", "the", "informed", "consent", "form", "through", "90", "days", "after", "the", "last", "dose", "of", "study", "drug", "and", "must", "also", "adhere", "to", "the", "guidelines", "of", "any", "treatment-specific", "pregnancy", "prevention", "program", ",", "if", "applicable", ",", "or", "agree", "to", "practice", "true", "abstinence", "when", "this", "is", "in", "line", "with", "the", "preferred", "and", "usual", "lifestyle", "of", "the", "subject" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03053453
1:26:chronic_disease
Ligamentous Insufficiency
3
[ "Ligamentous", "Insufficiency" ]
[ 2, 2 ]
NCT02323191
86:126:cancer,128:142:cancer,144:158:cancer,160:174:cancer,179:198:cancer
Participants must have histologically confirmed diagnosis of locally advanced and/or metastatic triple negative breast cancer, ovarian cancer, bladder cancer, gastric cancer, or soft tissue sarcoma
3
[ "Participants", "must", "have", "histologically", "confirmed", "diagnosis", "of", "locally", "advanced", "and/or", "metastatic", "triple", "negative", "breast", "cancer", ",", "ovarian", "cancer", ",", "bladder", "cancer", ",", "gastric", "cancer", ",", "or", "soft", "tissue", "sarcoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 3, 3, 0, 3, 3, 0, 3, 3, 0, 0, 3, 3, 3 ]
NCT02188745
18:23:cancer,69:75:treatment,,,151:162:treatment,166:181:treatment,208:212:treatment
Freshly acquired tumor specimens: As part of a clinically indicated biopsy procedure, an additional 1-3 cores or tissue fragments will be obtained by core needle or surgical biopsy for research purposes and FFPE
3
[ "Freshly", "acquired", "tumor", "specimens", ":", "As", "part", "of", "a", "clinically", "indicated", "biopsy", "procedure", ",", "an", "additional", "1-3", "cores", "or", "tissue", "fragments", "will", "be", "obtained", "by", "core", "needle", "or", "surgical", "biopsy", "for", "research", "purposes", "and", "FFPE" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 1 ]
NCT01951885
1:17:cancer
Multiple myeloma
3
[ "Multiple", "myeloma" ]
[ 3, 3 ]
NCT02317991
37:49:chronic_disease,51:62:chronic_disease,83:88:chronic_disease,105:115:chronic_disease,117:133:chronic_disease,135:152:chronic_disease,154:168:chronic_disease,170:193:chronic_disease,195:213:chronic_disease,217:229:chronic_disease
Evidence or history of uncontrolled hypertension, proteinuria, non-healing wound, ulcer, bone fracture, hemoptysis, valvular disease, abdominal fistula, GI perforation, intra-abdominal abscess, bleeding diathesis or coagulopathy
3
[ "Evidence", "or", "history", "of", "uncontrolled", "hypertension", ",", "proteinuria", ",", "non-healing", "wound", ",", "ulcer", ",", "bone", "fracture", ",", "hemoptysis", ",", "valvular", "disease", ",", "abdominal", "fistula", ",", "GI", "perforation", ",", "intra-abdominal", "abscess", ",", "bleeding", "diathesis", "or", "coagulopathy" ]
[ 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2 ]
NCT02557321
,,190:195:treatment
At least 1 Injectable Lesion (i.e., cutaneous, subcutaneous, soft tissue, superficial nodal or palpable nodal lesion with longest diameter at least 5 mm that is suitable for injection with PV-10)
3
[ "At", "least", "1", "Injectable", "Lesion", "(", "i.e.", ",", "cutaneous", ",", "subcutaneous", ",", "soft", "tissue", ",", "superficial", "nodal", "or", "palpable", "nodal", "lesion", "with", "longest", "diameter", "at", "least", "5", "mm", "that", "is", "suitable", "for", "injection", "with", "PV-10", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT01967823
,,52:62:treatment
ANC greater than 1000/mm(3) without the support of filgrastim
3
[ "ANC", "greater", "than", "1000/mm", "(", "3", ")", "without", "the", "support", "of", "filgrastim" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03111121
41:51:allergy_name
Patients with contraindications towards sugammadex
3
[ "Patients", "with", "contraindications", "towards", "sugammadex" ]
[ 0, 0, 0, 0, 4 ]
NCT02210078
34:44:chronic_disease
Patients with other uncontrolled infections
3
[ "Patients", "with", "other", "uncontrolled", "infections" ]
[ 0, 0, 0, 0, 2 ]
NCT02502799
14:18:chronic_disease
Diagnosis of ADHD
3
[ "Diagnosis", "of", "ADHD" ]
[ 0, 0, 2 ]
NCT02122185
27:55:treatment
subjects who will undergo intraperitoneal chemotherapy
3
[ "subjects", "who", "will", "undergo", "intraperitoneal", "chemotherapy" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT03035890
1:17:chronic_disease
hepatitis B or C
3
[ "hepatitis", "B", "or", "C" ]
[ 2, 2, 2, 2 ]
NCT02442297
53:75:treatment,
Subjects should have been off other investigational antineoplastic therapy for two weeks prior to entry in this study
3
[ "Subjects", "should", "have", "been", "off", "other", "investigational", "antineoplastic", "therapy", "for", "two", "weeks", "prior", "to", "entry", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02763228
1:23:cancer
Stage IV breast cancer
3
[ "Stage", "IV", "breast", "cancer" ]
[ 3, 3, 3, 3 ]
NCT02058095
15:35:chronic_disease,59:87:chronic_disease,113:124:chronic_disease,140:158:chronic_disease
Patients with retinitis pigmentosa, previous diagnosis of nonischemic optic neuropathy, untreated proliferative retinopathy or unexplained visual disturbance
3
[ "Patients", "with", "retinitis", "pigmentosa", ",", "previous", "diagnosis", "of", "nonischemic", "optic", "neuropathy", ",", "untreated", "proliferative", "retinopathy", "or", "unexplained", "visual", "disturbance" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 2, 0, 0, 2, 2 ]
NCT02514083
1:23:chronic_disease,57:82:chronic_disease,87:148:chronic_disease,150:188:chronic_disease,193:230:chronic_disease
Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel or ulcerative colitis, symptomatic inflammatory bowel disease, or partial or complete bowel obstruction
3
[ "Malabsorption", "syndrome", ",", "disease", "significantly", "affecting", "gastrointestinal", "function", ",", "or", "resection", "of", "the", "stomach", "or", "small", "bowel", "or", "ulcerative", "colitis", ",", "symptomatic", "inflammatory", "bowel", "disease", ",", "or", "partial", "or", "complete", "bowel", "obstruction" ]
[ 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 0, 2, 2, 2, 2, 0, 0, 2, 2, 2, 2, 2 ]
NCT00809991
44:74:cancer
Histologically confirmed, locally confined adenocarcinoma of the prostate
3
[ "Histologically", "confirmed", ",", "locally", "confined", "adenocarcinoma", "of", "the", "prostate" ]
[ 0, 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT01853163
18:22:treatment
has received one GdCA injection at the standard dose
3
[ "has", "received", "one", "GdCA", "injection", "at", "the", "standard", "dose" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02494869
1:5:cancer
DCIS
3
[ "DCIS" ]
[ 3 ]
NCT02124772
41:44:cancer,48:51:cancer,52:58:cancer
Recurrent or refractory BRAFV600 mutant LGG or LCH tumors
3
[ "Recurrent", "or", "refractory", "BRAFV600", "mutant", "LGG", "or", "LCH", "tumors" ]
[ 0, 0, 0, 0, 0, 3, 0, 3, 3 ]
NCT02515773
70:102:chronic_disease
Diagnosed or told by a clinician that they have any of the following bipolar spectrum disorders (BSD)
3
[ "Diagnosed", "or", "told", "by", "a", "clinician", "that", "they", "have", "any", "of", "the", "following", "bipolar", "spectrum", "disorders", "(", "BSD", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT01570998
1:5:cancer
HER2 positive (as defined in Treatment Policy under HER2)
3
[ "HER2", "positive", "(", "as", "defined", "in", "Treatment", "Policy", "under", "HER2", ")" ]
[ 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02543866
1:19:chronic_disease
Bleeding diatheses
3
[ "Bleeding", "diatheses" ]
[ 2, 2 ]
NCT02452008
23:32:chronic_disease,38:41:chronic_disease,43:54:chronic_disease,59:70:chronic_disease
Have known history of infection with HIV, hepatitis B, or hepatitis C
3
[ "Have", "known", "history", "of", "infection", "with", "HIV", ",", "hepatitis", "B", ",", "or", "hepatitis", "C" ]
[ 0, 0, 0, 0, 2, 0, 2, 0, 2, 2, 0, 0, 0, 0 ]
NCT01696734
90:100:treatment
Patient has signed the informed consent document agreeing to the use of the study drug, domperidone
3
[ "Patient", "has", "signed", "the", "informed", "consent", "document", "agreeing", "to", "the", "use", "of", "the", "study", "drug", ",", "domperidone" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT01993810
1:16:chronic_disease,24:48:chronic_disease,59:74:treatment,
Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months
3
[ "Unstable", "angina", "and/or", "congestive", "heart", "failure", "requiring", "hospitalization", "within", "the", "last", "6", "months" ]
[ 2, 2, 0, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0 ]
NCT03121586
1:11:treatment
Olanzapine
3
[ "Olanzapine" ]
[ 1 ]
NCT01473628
1:25:chronic_disease
Unstable angina pectoris
3
[ "Unstable", "angina", "pectoris" ]
[ 2, 2, 2 ]
NCT02269293
5:29:chronic_disease
Any life-threatening illness, medical condition or organ system dysfunction which, in the investigator's opinion, could compromise the subject's safety, or put the study outcomes at undue risk
3
[ "Any", "life-threatening", "illness", ",", "medical", "condition", "or", "organ", "system", "dysfunction", "which", ",", "in", "the", "investigator", "'s", "opinion", ",", "could", "compromise", "the", "subject", "'s", "safety", ",", "or", "put", "the", "study", "outcomes", "at", "undue", "risk" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02338999
22:25:chronic_disease,,
Patients with severe SLE at baseline, as quantified as SLEDAI-2K >20
3
[ "Patients", "with", "severe", "SLE", "at", "baseline", ",", "as", "quantified", "as", "SLEDAI-2K", ">", "20" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02078102
30:73:treatment,
Patients must not have taken nonsteroidal antiinflammatory drugs (NSAID) in the past 14 days before treatment on this protocol
3
[ "Patients", "must", "not", "have", "taken", "nonsteroidal", "antiinflammatory", "drugs", "(", "NSAID", ")", "in", "the", "past", "14", "days", "before", "treatment", "on", "this", "protocol" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02514083
12:34:treatment
history of bilateral oophorectomy
3
[ "history", "of", "bilateral", "oophorectomy" ]
[ 0, 0, 1, 1 ]
NCT01555905
24:45:chronic_disease
Confirmed diagnosis of neuromuscular disease
3
[ "Confirmed", "diagnosis", "of", "neuromuscular", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02498613
46:76:cancer,80:112:cancer,154:160:treatment
Patients may not have features suggestive of myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) on peripheral blood smear or bone marrow biopsy
3
[ "Patients", "may", "not", "have", "features", "suggestive", "of", "myelodysplastic", "syndrome", "(", "MDS", ")", "or", "acute", "myelogenous", "leukemia", "(", "AML", ")", "on", "peripheral", "blood", "smear", "or", "bone", "marrow", "biopsy" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03171493
16:39:treatment
indication for Radical cystectomy (RC)
3
[ "indication", "for", "Radical", "cystectomy", "(", "RC", ")" ]
[ 0, 0, 1, 1, 1, 0, 0 ]
NCT02938559
,65:68:treatment,69:71:treatment,76:86:chronic_disease
Lifetime history of failure to respond to 4 or more sessions of CBT/CT for depression
3
[ "Lifetime", "history", "of", "failure", "to", "respond", "to", "4", "or", "more", "sessions", "of", "CBT/CT", "for", "depression" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2 ]
NCT01524536
27:39:treatment
Appropriate candidate for GC treatment after challenge
3
[ "Appropriate", "candidate", "for", "GC", "treatment", "after", "challenge" ]
[ 0, 0, 0, 1, 1, 0, 0 ]
NCT00887146
267:307:treatment
the 1p/19q analysis results will be accepted from the local site, as determined by either a locally available or reference laboratory (for US, must be Clinical Laboratory Improvement Act [CLIA] certified); acceptable methods for determination of 1p/19q loss include fluorescent in-situ hybridization (FISH), by genomic sequencing or methylomic analyses; US and Canadian sites must send a copy of the official report to the pathology coordinator and quality assurance specialist (QAS)
3
[ "the", "1p/19q", "analysis", "results", "will", "be", "accepted", "from", "the", "local", "site", ",", "as", "determined", "by", "either", "a", "locally", "available", "or", "reference", "laboratory", "(", "for", "US", ",", "must", "be", "Clinical", "Laboratory", "Improvement", "Act", "[", "CLIA", "]", "certified", ")", ";", "acceptable", "methods", "for", "determination", "of", "1p/19q", "loss", "include", "fluorescent", "in-situ", "hybridization", "(", "FISH", ")", ",", "by", "genomic", "sequencing", "or", "methylomic", "analyses", ";", "US", "and", "Canadian", "sites", "must", "send", "a", "copy", "of", "the", "official", "report", "to", "the", "pathology", "coordinator", "and", "quality", "assurance", "specialist", "(", "QAS", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02163317
8:19:treatment,
Use of finasteride within 30 days prior to registration
3
[ "Use", "of", "finasteride", "within", "30", "days", "prior", "to", "registration" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02664168
55:72:treatment
Subjects with a known history of poor compliance with medical treatment
3
[ "Subjects", "with", "a", "known", "history", "of", "poor", "compliance", "with", "medical", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02397889
1:18:chronic_disease,,
hyroid impairment, as reflected by TSH> 4.2 mU/L
3
[ "hyroid", "impairment", ",", "as", "reflected", "by", "TSH", ">", "4.2", "mU/L" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02057133
23:41:treatment,46:59:cancer,71:83:treatment,76:83:treatment,85:97:treatment,99:112:treatment,118:141:treatment,177:196:treatment,,223:246:treatment,,262:288:treatment,308:321:treatment,
Have discontinued all previous therapies for breast cancer (including chemotherapy, radiotherapy, immunotherapy, and investigational therapy), except for ongoing corresponding combination therapy, for at least 21 days for myelosuppressive agents or 14 days for nonmyelosuppressive agents prior to receiving study drug(s), and recovered from the acute effects of therapy (until the toxicity resolves to either baseline or at least Grade 1)
3
[ "Have", "discontinued", "all", "previous", "therapies", "for", "breast", "cancer", "(", "including", "chemotherapy", ",", "radiotherapy", ",", "immunotherapy", ",", "and", "investigational", "therapy", ")", ",", "except", "for", "ongoing", "corresponding", "combination", "therapy", ",", "for", "at", "least", "21", "days", "for", "myelosuppressive", "agents", "or", "14", "days", "for", "nonmyelosuppressive", "agents", "prior", "to", "receiving", "study", "drug", "(", "s", ")", ",", "and", "recovered", "from", "the", "acute", "effects", "of", "therapy", "(", "until", "the", "toxicity", "resolves", "to", "either", "baseline", "or", "at", "least", "Grade", "1", ")" ]
[ 0, 0, 0, 1, 1, 0, 3, 3, 0, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02155699
26:40:chronic_disease
people who are extremely claustrophobic
3
[ "people", "who", "are", "extremely", "claustrophobic" ]
[ 0, 0, 0, 0, 2 ]
NCT00959140
1:4:cancer,20:29:treatment,34:49:treatment
AML: Refractory to Induction and salvage therapy
3
[ "AML", ":", "Refractory", "to", "Induction", "and", "salvage", "therapy" ]
[ 3, 0, 0, 0, 1, 0, 1, 1 ]